UNSPSC 51391719: Etafedrine

This classification denotes a beta-adrenergic agonist with the molecular formula C12H19NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Y6VQU63E8, chemically known as benzyl alcohol, alpha-(1-(ethylmethylamino)ethyl)- but generally known as etafedrine, which bears US NIH Compound Identifier 10734. European Medicines Agency schedules Etafedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07256MIG. The term ETAFEDRINE is an International Non-Proprietary Name.

UNSPSC 51391719 Etafedrine is a Commodity code that captures pharmaceutical products procured by state and local health and human services agencies, though recent state and local solicitations tagged under this code show activity concentrated in broader pharmacy benefit programs and emergency-response pharmaceuticals rather than etafedrine specifically. Seminole County, Florida's IFB60459723LAS sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding for community health initiatives, with quarterly deliveries and fixed pricing on a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 to explore direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit manager and group purchasing organization channels, targeting vendors with experience in negotiated net pricing and outcomes-based contracting for self-insured state employee and retiree plans. Issuing bodies include state health departments and county health agencies managing pharmacy procurement, emergency response stockpiling, and employee benefit programs.

Recent activity appears concentrated in Florida and Texas, with Seminole County's naloxone procurement addressing opioid-response initiatives and the Texas HHS Commission's RFI indicating statewide interest in restructuring pharmaceutical sourcing at scale. The Seminole County IFB closed July 26, 2023, with e-procurement submission, drug-free workplace certification, E-Verify compliance, and potential FEMA funding contingencies. The Texas RFI closed April 3, 2026, functioning as a market-intelligence phase preceding formal RFP development rather than an immediate award vehicle. Neither solicitation names set-aside designations or disadvantaged-enterprise restrictions. The source provides no evidence of broader geographic or issuing-body activity under this Commodity code across other states or jurisdiction types beyond these two examples.